1. Nose H, Foo KT, Lim KB, Yokoyama T, Ozawa H, Kumon H. Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology. 2005. 65:493–497.
2. Kelly CE. Evaluation of voiding dysfunction and measurement of bladder volume. Rev Urol. 2004. 6:Suppl 1. 32–37.
3. Woodwell D. Office visit to urologists US, 1989-90, National Ambulatory Medical Care Survey. Advance Data from Vital and Health Statistics, no. 234. 1992. Bethesda, Maryland: National Center for Health Statistics;1–12.
4. Yang SK. How to determine the timing of surgery. J Korean Continence Soc. 2005. 9:Suppl. 41–50.
5. Yalla SV, Sullivan MP, Lecamwasam HS, DuBeau CE, Vickers MA, Cravalho EG. Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism. J Urol. 1995. 153:674–679.
6. Kaplan SA, Bowers DL, Te AE, Olsson CA. Differential diagnosis of prostatism: a 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy. J Urol. 1996. 155:1305–1308.
7. Bruskewitz RC, Larsen EH, Madsen PO, Dørflinger T. 3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol. 1986. 136:613–615.
8. Tempany CM, Partin AW, Zerhouni EA, Zinreich SJ, Walsh PC. The influence of finasteride on the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate. 1993. 22:39–42.
9. Abrams PH, Farrar DJ, Turner-Warwick RT, Whiteside CG, Feneley RC. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol. 1979. 121:640–642.
10. Lim KB, Ho H, Foo KT, Wong MY, Fook-Chong S. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction. Int J Urol. 2006. 13:1509–1513.
11. Mariappan P, Brown DJ, McNeill AS. Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study. J Urol. 2007. 178:573–577.
12. Cho HJ, Kang JY, Yoo TK. The International Prostate Symptom Score: discrepancies between self-administration and physician-administration. Korean J Urol. 2007. 48:500–504.
13. McConnell JD. Why pressure-flow studies should be optional and mandatory studies for evaluating men with benign prostatic hyperplasia. Urology. 1994. 44:156–158.
14. Wadie BS, Ibrahim EH, de la Rosette JJ, Gomha MA, Ghoneim MA. The relationship of the IPSS and objective parameters for diagnosing bladder outlet obstruction. Part I: when statistics fail. J Urol. 2001. 165:32–34.
15. Kim BH, Sohn JC, Park CH, Kim CI. The usefulness of intravesical prostatic protrusion and bladder wall thickness measurement using transabdominal ultrasound in patients with benign prostatic hyperplasia. Korean J Urol. 2005. 46:1180–1185.
16. Yuen JS, Ngiap JT, Cheng CW, Foo KT. Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume. Int J Urol. 2002. 9:225–229.
17. Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003. 91:371–374.
18. Park SY, Cho JS, Hong CH, Lee KS. The clinical value of residual urine checked by transrectal ultrasonography. Korean J Urol. 2007. 48:951–955.